Scorpius Holdings Inc (SCPX) Inventory Turnover Ratio, from third quarter 2025 to third quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Scorpius Holdings inc   (SCPX)
 

Scorpius Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Scorpius Holdings Inc 's inventory turnover ratio, the ratio that measures Scorpius Holdings Inc 's ability to manage its supply chain, sequentially decreased to 6.44 in the third quarter 2025, which does not come as a surprise, as the Scorpius Holdings Inc continue to experience headwinds, which also impact its supply chain. Scorpius Holdings Inc 's average inventory processing period in the Sep 30 2025 quarter, has increased to 57 days, from 35 days, in the Jun 30 2025 quarter.

Within Healthcare sector 61 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. 347.

SCPX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Scorpius Holdings Inc Market Share?

What is Inventory Turnover Ratio?




SCPX Inventory Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Inventory Growth 16.24 % 187.55 % -85.92 % -78.15 % -
Y / Y Cost of Sales Growth -82.94 % -74.5 % -59.91 % -52.52 % 56.33 %
Inventory Turnover Ratio (TTM) 6.44 10.29 16.25 6.76 5.88
SCPX's Total Ranking # 347 # 347 # 235 # 556 # 730
Average inventory processing period 57 35 22 54 62
Seq. Inventory Growth -0.09 % 0 % 2.5 % 13.5 % 147.16 %
Seq. Cost of Sales Growth -31.96 % -43.2 % -33.78 % -33.33 % 1.68 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 62
Overall Market # 347

Inventory Turnover Ratio Statistics
High Average Low
16.25 9.13 5.88
(Mar 31 2025)   (Sep 30 2024)




Financial Statements
Scorpius Holdings Inc 's Inventories $ 0 Millions Visit SCPX's Balance sheet
Scorpius Holdings Inc 's Cost of Revenues TTM $ 1 Millions Visit SCPX's Income Statement
What are SCPX's Sales? Visit SCPX's Sales by Segment

Other Inventory Turnover Ratios
Scorpius Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SCPX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SCPX's Competitors
Inventory Turnover Ratio for SCPX's Suppliers
Inventory Turnover Ratio for SCPX's Customers

You may also want to know
SCPX's Sales Growth Rates SCPX's Pe Price to earnings ratio SCPX's Receivables Turnover Ratio SCPX's Stock Quote
SCPX's Net Income Growth Rates SCPX's Ps Price to Sales ratio SCPX's Sales per Employee SCPX's Asset Turnover Ratio
SCPX's Net Margin SCPX's Pb Price to Book ratio SCPX's Financial Strength Ratios SCPX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Bespoke Extracts Inc  16.99 $ 0.751  Millions$ 0  Millions
Jin Medical International Ltd  15.77 $ 14.444  Millions$ 1  Millions
Precipio inc   14.82 $ 12.580  Millions$ 1  Millions
Neuronetics Inc   14.56 $ 64.000  Millions$ 4  Millions
Natera Inc   14.32 $ 766.129  Millions$ 54  Millions
Harvard Apparatus Regenerative Technology Inc   14.06 $ 0.622  Millions$ 0  Millions
The Oncology Institute Inc   13.93 $ 198.545  Millions$ 14  Millions
Aurinia Pharmaceuticals Inc   13.79 $ 29.418  Millions$ 2  Millions
Rockwell Medical inc   13.30 $ 63.000  Millions$ 5  Millions
Irhythm Holdings Inc   12.48 $ 207.000  Millions$ 17  Millions
Option Care Health Inc   11.31 $ 4,459.129  Millions$ 394  Millions
Cryo cell International Inc   10.70 $ 7.279  Millions$ 1  Millions
Genedx Holdings Corp   10.56 $ 121.000  Millions$ 11  Millions
Infusystem Holdings Inc  10.55 $ 62.977  Millions$ 6  Millions
Lifemd Inc   10.28 $ 32.000  Millions$ 3  Millions
Zevra Therapeutics Inc   9.32 $ 16.328  Millions$ 2  Millions
Earth Science Tech Inc   9.30 $ 6.220  Millions$ 1  Millions
Sotera Health Company  9.20 $ 506.000  Millions$ 55  Millions
National Vision Holdings Inc   8.82 $ 793.761  Millions$ 90  Millions
Lantheus Holdings Inc   8.82 $ 576.000  Millions$ 65  Millions
Collegium Pharmaceutical Inc   8.66 $ 322.661  Millions$ 37  Millions
Nutriband Inc   8.64 $ 1.515  Millions$ 0  Millions
Castle Biosciences Inc   8.61 $ 68.896  Millions$ 8  Millions
Aditxt Inc   8.52 $ 0.074  Millions$ 0  Millions
Cardiff Lexington Corporation  8.39 $ 4.531  Millions$ 1  Millions
Myriad Genetics Inc   8.35 $ 242.500  Millions$ 29  Millions
Star Equity Holdings Inc   8.32 $ 67.222  Millions$ 8  Millions
Novavax inc   8.19 $ 87.605  Millions$ 11  Millions
Warby Parker Inc   8.16 $ 387.000  Millions$ 47  Millions
Adaptive Biotechnologies Corporation  8.03 $ 71.180  Millions$ 9  Millions

Date modified: 2026-09-08T22:08:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.